Phase 2 Study - The Use of a Single 5 mg Dose of Zoledronic Acid in Complex Regional Pain Syndrome Patient.
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Pain
- Focus Therapeutic Use
- Acronyms Aclasta
- 05 May 2015 Planned initiation date changed to 1 Dec 2013.
- 05 May 2015 New trial record